Identifying Drug Resistant Signatures in Dysplastic and Malignant Haematopoietic Stem Cells

Back to search results

We will investigate the emergence of drug resistant dysplastic haematopoietic stem cells using patient derived blood stem cells and mouse xenograft models. Bone marrow derived haematopoietic stem cells from patients with myelodysplastic syndrome undergoing treatment on an investigator initiated clinical trial led by Professor Pimanda will be barcoded and transplanted into mice. Engrafted blood stem cells will be harvested before and after drug treatment for single cell genotyping and transcriptomics to identify drug resistant signatures. These data will be combined with proteomic analysis to identify markers of emerging drug resistant cells in primary patient samples and to identify drugs that will be tested in mouse xenograft models.

Apply Now
Supervisory team

Medical Sciences

Women's and Children's Health

Prince of Wales Clinical School

Apply Now

Please start your application by taking the self assessment. Download the editable MS Word version or download the non-editable PDF version (best for Mac or mobile devices). Once the self assessment form is completed, save as a PDF and upload along with your application.

One file only.
50 MB limit.
Allowed types: gif jpg png bmp eps tif pict psd txt rtf html odf pdf doc docx ppt pptx xls xlsx xml avi mov mp3 ogg wav bz2 dmg gz jar rar sit svg tar zip.
If you have not done so, please complete the self assessment PDF as noted above.